Chapman Marcus 4
4 · Seres Therapeutics, Inc. · Filed Feb 8, 2021
Insider Transaction Report
Form 4
Chapman Marcus
See Remarks
Transactions
- Award
Stock Option (Right to Buy)
2021-02-04+24,000→ 24,000 totalExercise: $26.34Exp: 2031-02-03→ Common Stock (24,000 underlying) - Award
Restricted Stock Units
2021-02-04+12,000→ 12,000 total→ Common Stock (12,000 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of Issuer common stock.
- [F2]The restricted stock units will vest and settle as to 25% of the restricted stock units on March 15, 2022. The remainder of the restricted stock units will vest and settle in 12 equal quarterly installments thereafter.
- [F3]The option will vest as to 25% of the shares on February 4, 2022. The remainder of the shares will vest in 12 equal quarterly installments thereafter.